Showing results (211-220 of 269) with videos related to
Sort By:
Pageof 27
Archives of Neurology|February 16, 2011
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean familyEun-Joo Kim, Young-Eun Park, Dae-Seong Kim, et al.Journal of Clinical Neurology (Seoul, Korea)|April 24, 2012
Medial temporal atrophy and memory dysfunction in poststroke cognitive impairment-no dementiaBeom Joon Kim, Mi-Young Oh, Myung Suk Jang, et al.Dementia and Geriatric Cognitive Disorders|October 10, 2022
The Effect of Hearing Loss on Cognitive Function in Subjective Cognitive DeclineSo Young Park, Seong Hee Ho, Yun Jeong Hong, et al.Plos One|June 25, 2016
Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative DisordersSol Moe Lee, Myungguen Chung, Jae Wook Hyeon, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 20, 2012
A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer's disease with white matter hyperintensitiesSam-Yeol Ha, Young Chul Youn, SangYun Kim, et al.Journal of Alzheimer'S Disease : JAD|December 18, 2023
A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging PerspectivesSeunghee Na, Chonghwee Lee, SeongHee Ho, et al.Alzheimer'S Research & Therapy|July 27, 2021
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid statusRosha Babapour Mofrad, Philip Scheltens, SangYun Kim, et al.Dementia and Geriatric Cognitive Disorders|February 3, 2018
A Methodological Perspective on the Longitudinal Cognitive Change after StrokeJae-Sung Lim, Maengseok Noh, Beom Joon Kim, et al.Alzheimer'S Research & Therapy|October 19, 2017
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ<sub>42</sub>Seong Soo A An, Byoung-Sub Lee, Ji Sun Yu, et al.Journal of Alzheimer'S Disease : JAD|March 23, 2026
Plasma glial fibrillary acidic protein as a potential biomarker for differentiating amyloid-negative subjective cognitive decline and mild cognitive impairmentBora Yoon, Hyuk-Je Lee, Hyojin Chae, et al.Pageof 27